Judy Hahn

Judy Hahn, PhD, MA, is a distinguished Professor in Residence within the HIV, ID, and Global Medicine Division at the Department of Medicine at the University of California-San Francisco. Her academic and research pursuits are deeply rooted in the complex interplay between substance use and infectious diseases, with a particular emphasis on individuals co-infected with HIV and tuberculosis who also struggle with alcohol use. Dr. Hahn's work is pivotal in advancing our understanding of these intersecting health challenges. Dr. Hahn is at the forefront of several NIH-funded research initiatives that focus on TB prophylaxis and innovative interventions aimed at reducing alcohol consumption and enhancing adherence to antiretroviral therapy. Her research employs cutting-edge biomarkers to obtain objective data in contexts where traditional self-reporting methods may be unreliable. This approach not only enriches the scientific community's understanding but also contributes to the development of more effective public health strategies. In addition to her research endeavors, Dr. Hahn is actively engaged in teaching and mentoring the next generation of researchers and healthcare professionals. She plays a significant role in grant-writing courses and is a key contributor to various programs at UCSF, including the Clinical and Translational Science Institute (CTSI) KL2 Scholars Program. Her commitment to education and mentorship is evident in her dedication to fostering a collaborative and supportive learning environment. Dr. Hahn's contributions to the field have been recognized through numerous awards, including those from the Center for AIDS Research (CFAR). One of her notable achievements is the development of a self-administered digital health screener designed to address unhealthy alcohol use among individuals living with HIV in Uganda. This innovative tool exemplifies her commitment to creating practical solutions that can be implemented in diverse global settings. Through her work, Dr. Hahn continues to make significant strides in addressing the dual challenges of substance use and infectious diseases. Her research not only informs clinical practices but also shapes public health policies aimed at improving the lives of vulnerable populations worldwide. Her dedication to her field and her contributions to both research and education make her a respected leader in the global health community.